FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology and immunology. Disclosed is a method of producing polyspecific antibodies, including a full-size antibody specifically bound to a first antigen and consisting of two heavy chains and two light chains of antibody, and one or more single-chain fragments Fab bound with one or more additional antigens, wherein said single Fab fragments are bound with said full-size antibody through a peptide connector at C-end of heavy or light chain of said full-size antibody, wherein peptide connector has a structure (GxS)n or (GxS)(G)m, where G = glycine, S = serine, and (x = 3, n = 3, 4, 5 or 6 and m = 0, 1, 2 or 3) or (x = 4, n = 2, 3, 4 or 5 and m = 0, 1, 2 or 3). Polyspecific antibodies produced by disclosed method have good stability and low tendency to aggregation.
EFFECT: method of present invention can be used in preparing medicinal agents.
5 cl, 15 dwg, 3 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
TRI- OR TETRASPECIFIC ANTIBODIES | 2010 |
|
RU2570633C2 |
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES | 2009 |
|
RU2542382C2 |
BISPECIFIC ANTI-VEGF/ANTI-ANG-2 ANTIBODIES | 2014 |
|
RU2640253C2 |
HUMANISED HUMAN CD19 ANTIBODIES AND METHODS FOR USE THEREOF | 2016 |
|
RU2731156C1 |
MULTISPECIFIC ANTIBODY CONSTRUCTS | 2015 |
|
RU2710730C2 |
DUAL VARIABLE REGION ANTIBODY-LIKE BINDING PROTEINS HAVING CROSS-OVER BINDING REGION ORIENTATION | 2012 |
|
RU2695880C2 |
ANTI-LRP6 ANTIBODIES | 2011 |
|
RU2587625C2 |
ANTIBODIES BINDING TO GPRC5D | 2019 |
|
RU2797268C2 |
UNIVERSAL TRANSMITTER MODULES THROUGH THE HEMATOENCEPHALITIC BARRIER | 2014 |
|
RU2799436C1 |
MONOVALENT CARRIER MODULES ACROSS BLOOD-BRAIN BARRIER | 2014 |
|
RU2694659C2 |
Authors
Dates
2016-09-20—Published
2010-03-30—Filed